31
Participants
Start Date
Not specified
Study Completion Date
September 30, 2007
Lopinavir/Ritonavir
Bronx-Lebanon Hosp. IMPAACT CRS, The Bronx
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology, Baltimore
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore
Univ. of Florida Jacksonville NICHD CRS, Jacksonville
St. Jude/UTHSC CRS, Memphis
Chicago Children's CRS, Chicago
Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab., Oakland
UCSF Pediatric AIDS CRS, San Francisco
Univ. of Colorado Denver NICHD CRS, Aurora
Children's National Med. Ctr. Washington DC NICHD CRS, Washington D.C.
USF - Tampa NICHD CRS, Tampa
St. Christopher's Hosp. for Children, Philadelphia
SOM Federal University Minas Gerais Brazil NICHD CRS, Minas Gerais
Univ. of Sao Paulo Brazil NICHD CRS, São Paulo
San Juan City Hosp. PR NICHD CRS, San Juan
Children's Hosp. of Boston NICHD CRS, Boston
Baystate Health, Baystate Med. Ctr., Springfield
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH